Tallman, M. S. (2025) “Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the PROS”, Haematologica. Pavia, Italy, 110(7), pp. 1454-1458. doi: 10.3324/haematol.2025.287417.